In last trading session, Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) saw 0.49 million shares changing hands with its beta currently measuring -0.54. Company’s recent per share price level of $3.30 trading at -$0.22 or -6.25% at ring of the bell on the day assigns it a market valuation of $282.78M. That closing price of AMLX’s stock is at a discount of -504.55% from its 52-week high price of $19.95 and is indicating a premium of 52.12% from its 52-week low price of $1.58.
For Amylyx Pharmaceuticals Inc (AMLX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.75. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) trade information
Upright in the red during last session for losing -6.25%, in the last five days AMLX remained trading in the red while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $3.30 price level, adding 14.95% to its value on the day. Amylyx Pharmaceuticals Inc’s shares saw a change of -12.70% in year-to-date performance and have moved -8.08% in past 5-day. Amylyx Pharmaceuticals Inc (NASDAQ:AMLX) showed a performance of -5.17% in past 30-days.
Wall Street analysts have assigned a consensus price target of 9 to the stock, which implies a rise of 63.33% to its current value. Analysts have been projecting 4 as a low price target for the stock while placing it at a high target of 11. It follows that stock’s current price would drop -21.21% in reaching the projected high whereas dropping to the targeted low would mean a loss of -21.21% for stock’s current value.
Amylyx Pharmaceuticals Inc (NASDAQ:AMLX)’s Major holders
VANGUARD GROUP INC is the top institutional holder at AMLX for having 4.22 million shares of worth $8.03 million. And as of 2024-06-30, it was holding 6.2251 of the company’s outstanding shares.
The second largest institutional holder is AQR CAPITAL MANAGEMENT LLC, which was holding about 3.34 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.9114 of outstanding shares, having a total worth of $6.35 million.
On the other hand, Vanguard Total Stock Market Index Fund and abrdn Healthcare Investors are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 1.81 shares of worth $5.98 million or 2.64% of the total outstanding shares. The later fund manager was in possession of 1.37 shares on Sep 30, 2024 , making its stake of worth around $4.52 million in the company or a holder of 2.00% of company’s stock.
